Please login to the form below

Not currently logged in
Email:
Password:

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

Engelbert Tjeenk Willink, member of the board of managing directors at Boehringer Ingelheim responsible for marketing and sales of prescription medicines, is to leave the German pharma company at the end of 2012.

He will be replaced by current head of established markets Allan Hillgrove, who takes over from January 1, 2013.

Tjeenk Willink has been in his current role since 2009, having originally joined Boehringer in 1994 as a medical director. Other positions he has held during his time at the company include head of marketing and sales in Canada, head of marketing for prescription medicines and country manager of Boehringer in Mexico.

Boehringer - Engelbert Tjeenk WillinkBoehringer - Allan Hillgrove

Engelbert Tjeenk Willink (left) and Allan Hillgrove (right)

“We are sorry to see him go and wish him all the best in his future professional and personal life,” said Christian Boehringer, chair of the shareholders committee, and Professor Andreas Barner, chair of the board, in a joint statement.

“Tjeenk Willink has worked with passion and enthusiasm for Boehringer Ingelheim. In his various roles in Ingelheim and abroad, he contributed significantly to the positive development of the group.”

His replacement, Hillgrove, has been with Boehringer since 1982, and has been in his current role since 2010.

“In his various roles he has helped to set the course for sustained growth in recent years,” said Boehringer and Barner in their joint statement.

“Shareholders and board members are convinced that with this staffing arrangement the board of managing directors will be well equipped for the various challenges that lie ahead for Boehringer Ingelheim and the research-driven pharmaceutical industry worldwide."

28th September 2012

From: Sales

Share

Tags



Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FTI Consulting

Our pharmaceutical and life sciences team understands the legal and regulatory challenges confronting pharmaceutical companies and provides strategic counsel in...

Latest intelligence

Designing Human Experiences
Applying science to the creative process to improve lives...
Assured Global Delivery at The Right Temperature®
CSafe Global partners with DHL Global Forwarding to assure pharmaceutical manufacturer successful temperature sensitive delivery to South America....
The changing regulatory environment
Code of practice changes are encouraging transparency in pharma/HCP relationships...